4/A//SEC Filing
Lavino Francesco Maria 4/A
Accession 0001104659-19-047347
CIK 0001641640other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 9:34 PM ET
Size
5.0 KB
Accession
0001104659-19-047347
Insider Transaction Report
Form 4/AAmended
Lavino Francesco Maria
Chief Commercial Officer
Transactions
- Sale
Ordinary Shares
2019-08-21$2.08/sh−3,797$7,898→ 11,172 total
Footnotes (1)
- [F1]This amendment is being filed solely to correct the transaction code from "F" to "S" for the sale of ordinary shares to satisfy tax withholding obligations in connection with the transaction reported in the Form 4 filed by the reporting person on August 21, 2019.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001711517
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 9:34 PM ET
- Size
- 5.0 KB